814 related articles for article (PubMed ID: 18408596)
21. Elevated human beta-defensin-2 levels indicate an activation of the innate immune system in patients with irritable bowel syndrome.
Langhorst J; Junge A; Rueffer A; Wehkamp J; Foell D; Michalsen A; Musial F; Dobos GJ
Am J Gastroenterol; 2009 Feb; 104(2):404-10. PubMed ID: 19174795
[TBL] [Abstract][Full Text] [Related]
22. Pitfalls in the interpretation of nonneoplastic mucosal biopsies in inflammatory bowel disease.
Yantiss RK; Odze RD
Am J Gastroenterol; 2007 Apr; 102(4):890-904. PubMed ID: 17324129
[TBL] [Abstract][Full Text] [Related]
23. Butyrate increases colonocyte protein synthesis in ulcerative colitis.
Frankel W; Lew J; Su B; Bain A; Klurfeld D; Einhorn E; MacDermott RP; Rombeau J
J Surg Res; 1994 Jul; 57(1):210-4. PubMed ID: 8041140
[TBL] [Abstract][Full Text] [Related]
24. IL-18, a novel immunoregulatory cytokine, is up-regulated in Crohn's disease: expression and localization in intestinal mucosal cells.
Pizarro TT; Michie MH; Bentz M; Woraratanadharm J; Smith MF; Foley E; Moskaluk CA; Bickston SJ; Cominelli F
J Immunol; 1999 Jun; 162(11):6829-35. PubMed ID: 10352304
[TBL] [Abstract][Full Text] [Related]
25. Multigene analysis can discriminate between ulcerative colitis, Crohn's disease, and irritable bowel syndrome.
von Stein P; Lofberg R; Kuznetsov NV; Gielen AW; Persson JO; Sundberg R; Hellstrom K; Eriksson A; Befrits R; Ost A; von Stein OD
Gastroenterology; 2008 Jun; 134(7):1869-81; quiz 2153-4. PubMed ID: 18466904
[TBL] [Abstract][Full Text] [Related]
26. The increased expression of an array of C-X-C and C-C chemokines in the colonic mucosa of patients with ulcerative colitis: regulation by corticosteroids.
Yang SK; Choi MS; Kim OH; Myung SJ; Jung HY; Hong WS; Kim JH; Min YI
Am J Gastroenterol; 2002 Jan; 97(1):126-32. PubMed ID: 11808935
[TBL] [Abstract][Full Text] [Related]
27. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
[TBL] [Abstract][Full Text] [Related]
28. Expression of p53 antigen in inflamed and regenerated mucosa in ulcerative colitis and Crohn's disease.
Krishna M; Woda B; Savas L; Baker S; Banner B
Mod Pathol; 1995 Aug; 8(6):654-7. PubMed ID: 8532700
[TBL] [Abstract][Full Text] [Related]
29. Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis.
Vainer B; Sørensen S; Nielsen OH; Horn T
Ultrastruct Pathol; 2002; 26(2):113-21. PubMed ID: 12036091
[TBL] [Abstract][Full Text] [Related]
30. Predicting a change in diagnosis from ulcerative colitis to Crohn's disease: a nested, case-control study.
Melmed GY; Elashoff R; Chen GC; Nastaskin I; Papadakis KA; Vasiliauskas EA; Liu W; Landers C; Ippoliti AF; Targan SR
Clin Gastroenterol Hepatol; 2007 May; 5(5):602-8; quiz 525. PubMed ID: 17478347
[TBL] [Abstract][Full Text] [Related]
31. Comparing the type and severity of inflammatory bowel disease in relation to IgG4 immunohistochemical staining.
Şimşek HD; Basyigit S; Aktas B; Vargol E; Şimşek GG; Küçükazman M; Nazlıgül Y
Acta Gastroenterol Belg; 2016; 79(2):216-21. PubMed ID: 27382941
[TBL] [Abstract][Full Text] [Related]
32. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
Li MR; Jiang K; Zhang QY
Zhonghua Yi Xue Za Zhi; 2008 Apr; 88(14):957-60. PubMed ID: 18756966
[TBL] [Abstract][Full Text] [Related]
33. Cellular immune response against tropomyosin isoform 5 in ulcerative colitis.
Taniguchi M; Geng X; Glazier KD; Dasgupta A; Lin JJ; Das KM
Clin Immunol; 2001 Dec; 101(3):289-95. PubMed ID: 11726221
[TBL] [Abstract][Full Text] [Related]
34. Increased expression of tumor necrosis factor-alpha messenger RNA in the intestinal mucosa of inflammatory bowel disease, particularly in patients with disease in the inactive phase.
Akazawa A; Sakaida I; Higaki S; Kubo Y; Uchida K; Okita K
J Gastroenterol; 2002; 37(5):345-53. PubMed ID: 12051533
[TBL] [Abstract][Full Text] [Related]
35. Differences in goblet cell differentiation between Crohn's disease and ulcerative colitis.
Gersemann M; Becker S; Kübler I; Koslowski M; Wang G; Herrlinger KR; Griger J; Fritz P; Fellermann K; Schwab M; Wehkamp J; Stange EF
Differentiation; 2009 Jan; 77(1):84-94. PubMed ID: 19281767
[TBL] [Abstract][Full Text] [Related]
36. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
[TBL] [Abstract][Full Text] [Related]
37. Tropomyosin expression in the ileal pouch: a relationship with the development of pouchitis in ulcerative colitis.
Biancone L; Palmieri G; Lombardi A; Colantoni A; Tonelli F; Das KM; Pallone F
Am J Gastroenterol; 2003 Dec; 98(12):2719-26. PubMed ID: 14687823
[TBL] [Abstract][Full Text] [Related]
38. Changes in the expression and distribution of the inducible and endothelial nitric oxide synthase in mucosal biopsy specimens of inflammatory bowel disease.
Palatka K; Serfozo Z; Veréb Z; Hargitay Z; Lontay B; Erdodi F; Bánfalvi G; Nemes Z; Udvardy M; Altorjay I
Scand J Gastroenterol; 2005 Jun; 40(6):670-80. PubMed ID: 16036527
[TBL] [Abstract][Full Text] [Related]
39. Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.
Hafer A; Krämer S; Duncker S; Krüger M; Manns MP; Bischoff SC
BMC Gastroenterol; 2007 Sep; 7():36. PubMed ID: 17784949
[TBL] [Abstract][Full Text] [Related]
40. Increased expression of interleukin-12 receptor beta(2) on lamina propria mononuclear cells of patients with active Crohn's disease.
Stallmach A; Marth T; Adrian N; Wittig BM; Ecker KW; Schilling M; Zeitz M
Int J Colorectal Dis; 2002 Sep; 17(5):303-10. PubMed ID: 12172923
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
